The NLRP3 and NLRP6 inflammasomes are known to reduce IL-22 binding protein levels, leading to an uncontrolled increase in IL-22 and subsequent stimulation of colon cancer 97. The gene discussed is IL22; the disease is malignant colon neoplasm.